Rupture of the ventricular septum during acute myocardial infarction usually occurs within the first week. The event is usually followed by low cardiac output, heart failure, and multiorgan failure. Despite the many advances in the nonoperative treatment of heart failure and cardiogenic shock, including the intra-aortic balloon pump and a multitude of new inotropic agents and vasodilators, these do not supplant the need for operative intervention in these critically ill patients. This article describes the successful use of extracorporeal membrane oxygenation support as a bridge to recovery postoperatively in a patient with a large infarctproduced ventricular septal defect.
A lthough short-term mortality remains high in patients with postinfarction ventricular septal defects (VSDs), the long-term prognosis is promising for those who survive the fi rst 30 days. Davies et al reported that, among 60 patients who survived surgical repair, the 5-, 10-, and 15-year survival rate was 69%, 50%, and 37%, respectively ( 1 ) . While nonsurgical treatment of infarct-produced VSD has an early mortality of >90% ( 2 ), surgical repair may have better outcomes. Surgical closure of infarct-produced VSD in patients in cardiogenic shock is rarely described. Here we describe a case treated successfully with extracorporeal membrane oxygenation (ECMO) support as a bridge to recovery postoperatively in a patient with a large infarct-associated VSD.
CASE REPORT
A 69-year-old man with coronary artery disease presented with 6 days of substernal chest pain. At age 65, he underwent percutaneous coronary intervention of the left anterior descending coronary artery. On arrival at the emergency department, he was found to have an ST-elevation myocardial infarction. Cardiac catheterization revealed a completely occluded posterior descending artery, and it was stented. In the catheterization laboratory, the patient developed cardiogenic shock, and an intra-aortic balloon pump (IABP) was placed. A bedside echocardiogram revealed a VSD ( Figure 1 ) . Th e patient experienced cardiac arrest in the intensive care unit and was resuscitated with 10 minutes of cardiopulmonary resuscitation. At this point, peripherally cannulated venoarterial ECMO was initiated. In the following 24 hours, his liver and renal function deteriorated; surgery was deferred for another 24 hours to optimize liver and kidney function, and vasoactive and inotropic medications were reduced.
On day 3 of venoarterial ECMO, the VSD was operatively closed. Th e VSD, located posteriorly, was approximately 2 × 1 cm in diameter. It was repaired by a double patch technique 
, with a pericardial patch reconstructing the septum and reducing the postrepair tension in the defect. A portion of the patch was secured on the left side of the ventricular septum, and the other portion of the patch was secured by pledgeted stitches. Th e left ventriculotomy was closed by a large ventricular patch, again using interrupted pledgeted stitches. Th e ECMO was converted to central cannulation to decrease tension on the pericardial patch by keeping the heart decompressed and was continued postoperatively.
On day 6 of venoarterial ECMO, the patient was on lowdose vasopressors and required a fl ow of 2.0 to 3.0 L. Th e patient was separated from ECMO, the chest was closed, and an IABP was kept in place. Th e patient returned to the intensive care unit with good biventricular function but required an increase in vasopressors. Nitric oxide and dobutamine were also needed to maintain hemodynamics. Over the next 4 days, the patient was weaned off nitric oxide and required lower doses of vasopressors. Th e IABP was removed. Within 7 days, the patient was completely weaned off vasopressors and inotropes. Th e patient spent 2 months in a rehabilitation facility and fully recovered, and he has continued to do well 18 months after surgery.
DISCUSSION
Postinfarction VSD repair remains a surgically challenging procedure with a high risk of mortality and morbidity ( 3, 4 ) , partly due to the recurrence of VSD in 10% to 50% of cases (5) (6) (7) (8) . Better patient management over the years may have played a part in improving surgical results of postinfarction VSD. At our institution, the use of the double patch technique and ECMO support in the recovery period might have led to avoiding the recurrence of VSD, thus reducing hospital mortality. Th erefore, this technique is to be recommended in the early repair of postinfarction VSD.
VSD operative mortality remains high. In a study by Pang et al ( 9 ) , the 30-day operative mortality of postinfarction VSD was 40%, with an overall survival at 10 years near 50%. Birnbaum et al found that the mortality rate among patients with septal rupture who were treated conservatively without mechanical closure was approximately 24% in the fi rst 24 hours, 46% at 1 week, and 67% to 82% at 2 months ( 10 ). Operative mortality depends on preoperative hemodynamics, which in turn depends on the degree of shunting and the extent of the acute infarct ( 11 ). Park et al ( 2 ) studied 34 patients who underwent surgical repair of postinfarct VSD over 22 years in a single center, showing a 30-day mortality of 21% (7 patients), with profound cardiac failure as the cause of death. After 30 days, two patients died of sepsis and another died of subdural hemorrhage, resulting in an in-hospital mortality of 31%. Th e 5-and 10-year survival rates were 54% and 44%, respectively. Th ese authors agreed that preoperative cardiogenic shock, systolic blood pressure, and right atrial pressure, along with cardiopulmonary bypass time, are major contributors to operative mortality. On the other hand, ejection fraction and the size of the intracardiac shunt were not determinants in postoperative outcome. Furthermore, the combination of elevated right atrial pressure with low systemic blood pressure was associated with an extremely poor prognosis ( 2, 10 ) .
Th e ideal timing of VSD repair is a point for debate ( Table 1 ) ( 2, 5, 9, (12) (13) (14) . A few studies support our current strategy of delaying surgery, allowing optimization of medical management prior to intervention if permissible. Pang et al ( 9 ) found that only 2 of 38 patients remained suffi ciently stable in New York Heart Association Class II to permit delayed surgery. Essentially, their study showed that delayed surgery only applied to a select group of patients who remain hemodynamically stable. An earlier study of 43 patients found that early surgical repair actually increased the survival rate ( 7 ). According to Gregoric et al ( 15 ) , the myocardial VSD edges are friable and the VSD enlarges during the fi rst 10 days after acute myocardial infarction, so although awaiting myocardial maturation is ideal it is not entirely possible.
Th e technique used to close the VSD also has importance; studies have shown that double patch techniques may decrease the incidence of residual shunt ( 9 ) . In the study by Pang et al ( 9 ) , the surgeons performed the single patch technique and had a 24% incidence of postoperative residual shunt. Utilizing viable myocardium and excluding the fragile infarcted myocardial tissue when suturing the pericardial patch also prevents recurrence ( 2 ) . Concomitant coronary revascularization may prevent further risk of ischemic injury to the myocardium. While small VSDs may be repaired using percutaneous closure devices, large VSDs (20 × 15 mm), such as in the present case, should undergo immediate surgery, as they are prone to device embolization or residual defect. Contraindications to percutaneous device closure also include inappropriate anatomy to land the device and the location of the VSD ( 15 ) .
Ventricular assist devices (VADs) have been shown to be benefi cial in the setting of univentricular or biventricular failure. Typically VADs are used as a bridge to surgery or are placed postoperatively to allow for restoration of peripheral organ perfusion and provide recovery and maturation of the infarcted myocardium. By decreasing afterload and preload, VADs can help in providing rest for the myocardium. IABP placement can also be utilized to decrease afterload and increase coronary perfusion to the shocked myocardium. Blanche et al ( 16 ) found that postoperative use of an IABP reduces immediate postoperative mortality but does not improve longterm survival. Rohn et al ( 11 ) used venoarterial ECMO and an IABP to help stabilize a patient and surgically repair the VSD. Venoarterial ECMO was used as a VAD, allowing the patient to stabilize and improve clinically. On the third day, they were able to close the VSD, perform mitral valve plasty, and bypass the right coronary artery. Th e patient was doing well 6 months after surgery. Delayed surgery may be required to allow fi brous myocardial tissue growth and to prevent recurrence of VSD and dehiscence of the surgical patch. Percutaneous ECMO provides numerous benefi ts compared with placement of a conventional VAD. ECMO is economically effi cient, prevents sternotomy, provides oxygenation support, and is easily reversible. 
